Basis: (FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-10-06T22:42:37.070Z.
Calculation as of: 2026-10-06T22:42:37.070Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: c752279377b025acf72c3dd079155b3811244be546b74823e0a9f28be94cffb5
PEG RATIO
N/A
Nano-X Imaging Ltd.
Market Cap
$42.83M
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| Nano-X Imaging Ltd. (NNOX) | $42.83M | N/A |
| Rapid Micro Biosystems, Inc. (RPID)vs › | $42.72M | N/A |
| CVRx, Inc. (CVRX)vs › | $42.99M | N/A |
| Filana Therapeutics, Inc. (FLNA)vs › | $42.26M | N/A |
| BioStem Technologies, Inc. (BSEM)vs › | $41.95M | N/A |
| Precipio, Inc. (PRPO)vs › | $41.83M | N/A |
| DarioHealth Corp. (DRIO)vs › | $44.02M | N/A |
| SANUWAVE Health Inc. (SNWV)vs › | $44.71M | N/A |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $44.72M | N/A |
| Celularity Inc. (CELU)vs › | $45.73M | N/A |
PEG Ratio
N/A
P/E Ratio
N/A
PEG Ratio = P/E Ratio / 5-Year Diluted EPS CAGR (%)
The PEG ratio divides the price-to-earnings ratio by the company's five-year compound annual growth rate of diluted EPS, expressed in percent. A P/E of 20 and a five-year diluted EPS CAGR of 10% give a PEG of 2.0. The growth is reported, historical earnings growth from annual statements, not an analyst forecast. A PEG near 1 is often read as fairly priced for its growth; lower can mean cheaper relative to growth. The ratio is N/A when the P/E is unavailable or not positive, or when the five-year diluted EPS CAGR is unavailable or not positive. Each day of the history uses the CAGR that was known on that day.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
